The Obamacare Fears Crushing this Insurance Stock

Uncertainty over federal subsidies is sinking Centene stock

Managing Editor
Oct 24, 2017 at 2:23 PM
facebook X logo linkedin


Stocks are significantly higher this afternoon, with the Dow hitting a fresh record high. Healthcare company Centene Corp (NYSE:CNC) is down, while Jeep parent Fiat Chrysler Automobiles NV (NYSE:FCAU) and biotech stock Pain Therapeutics, Inc. (NASDAQ:PTIE) are enjoying breakout sessions. Here's a quick look at what is moving shares of CNC, FCAU, and PTIE.

CNC Stock Plummets Over Federal Subsidy Uncertainties 

Centene stock is down 3.8% to trade at $94.29, dipping lower after the healthcare company predicted it could lose 7-12 cents off its fourth-quarter earnings due to President Trump's decision to cut off Obamacare subsidies. However, the shares have found familiar support from its 50-day moving average, and is still up 66% year-to-date. Meanwhile, analysts may need to reconsider their bullish positions. Of the 16 brokerages that cover CNC, 12 rate the shares a "buy" or "strong buy."

Fiat Chrysler Stock Flirting With Record Highs After Earnings Beat

This morning, Fiat Chrysler joined rival General Motors in reporting third-quarter earnings that exceeded Wall Street expectations. The news has FCAU stock up 5.8% to trade at $17.51, and flirting with the record high of $18.10 it set on Sept. 22. It's been a stellar run for the equity, adding a whopping 172% year-over-year, and it has outperformed the broader S&P 500 Index (SPX) by nearly 32 percentage points during the past three months.

In the options pits, call buying has been vastly more popular than put buying in recent months at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This is according to the equity's 50-day call/put volume ratio of 5.12, which ranks in the 86th percentile of its annual range.

Pain Therapeutics Top Of The Nasdaq After Alzheimer's Drug News

Pain Therapeutics stock is up over 38% to trade at $5.14, after PTI-125, the biotech's experimental drug for Alzheimer's, succeeded in early stage testing. The news takes PTIE stock to its highest point since April, but it topped out right at its 320-day moving average. Short sellers are likely sweating this sudden surge nonetheless. While short interest has decreased by 2% during the last reporting period, it accounts for 10% of the total available float. 
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI